Skip to main content
. 2022 Mar 5;14:87–100. doi: 10.2147/HIV.S348076

Figure 2.

Figure 2

The Kaplan–Meier survival curve by regimen change for time to switch to 2nd line Anti-Retroviral Therapy (ART) and its predictors among HIV-infected adults at high load public health facilities Northwest Ethiopia, from 2016 to 2020 (n=427). (Blue line=survival curve of patients with 1st line regimen change, Black line = survival curve of patients with 1st line regimen change).